BridgeMD
New treatment option for Attention-Deficit/Hyperactivity Disorder (ADHD)
Official title Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder
ClinicalTrials.gov ID: NCT04532190
What this study is testing
- What it's testing
- Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by poor attention, impulsivity, hyperactivity and emotional-motivational dysregulation. Here, we will test if theta burst repetitive transcranial magnetic stimulation (rTMS) can reduce the symptoms of ADHD.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 9 to 15
You may be able to join if
- Diagnosis of ADHD
- 9-15 years old
- IQ greater than 80
- English fluency (to enable consent/assent)
- If on medication, must have been on the same type and dosage for at least 3 months.
You likely can't join if
- Diagnosis of mania, psychosis, or bipolar disorder
- Impediments to TMS or MRI (i.e. metal implants in body)
- Prior electroconvulsive therapy or vagus nerve stimulation
- Diagnosis of Autism Spectrum Disorder.
The study team makes the final eligibility decision.
Where it's taking place
- Calgary, Alberta, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 9 years to 15 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Calgary, Alberta, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.